Abstract
Recombinant HMGB1 selectively induces IL-1β release from human monocytes. Moreover, HMGB1-induced IL-1β secretion remains unaltered following BLP tolerisation. Hence, changes in HMGB1-induced proinflammatory cytokine release cannot explain the beneficial effects of BLP on sepsis-related lethality.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.